Scrip's Five Must-Know Things - 11 March 2024

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer won’t split, for now; Pfizer’s next-gen ADC pipeline; oncology dominates investment but other areas grow; goodbye NASH, hello MASH; and BMS’s CEO gives his views on India. Links to the stories discussed are here: https://scrip.citeline.com/SC149924/Quick-Listen-Scrips-Five-MustKnow-Things